Huang Duoqin, Luo Zixin, Song Xinyue, Zou Kang
The First Clinical Medical College, Gannan Medical University, Ganzhou, China.
Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Front Pharmacol. 2024 Sep 26;15:1412726. doi: 10.3389/fphar.2024.1412726. eCollection 2024.
The application of sufentanil of anesthesiology has become a popular research area. However, literature-based bibliometric analyses on sufentanil are limited. Therefore, this study aimed to review the application of sufentanil in anesthesiology, and evaluate the research status and trends in this field.
We searched the SCI-Expanded, SSCI, and CPCI-S databases from the Web of Science core collection as data sources for articles published from 1 January2003, to 31 December2023, and bibliometric and VOSviewer software were used to visualize and analyze the literature in terms of authors, journals, countries, institutions, and their collaborative networks, as well as keyword networks.
Our analysis included 1,473 relevant publications on the application of sufentanil in anesthesiology. The overall number of publications is on the rise; the top three countries of study were China, the US and France; the top three universities that published relevant articles were Anhui Medical University, Capital Medical University and Zhejiang University; the largest number of publications focused on ; At present, the studies in this field mainly focus on the application scope, mode, and advantages; adverse reactions; and combined effects of sufentanil in combination with other drugs. The adverse factors for the use of sufentanil in anesthesiology and ways to improve its safety and efficacy are hot topics of research. Future research should explore the applicability of population and dose utilization, novel drug combinations, non-opioid adjuncts, and technological innovations.
An increasing number of publications indicates that researchers are showing interest in the field of sufentanil use in anesthesiology, and ongoing research is at a relatively mature level. While the international community has established a strong foundation for cooperation, the cooperation among researchers, institutions, and countries needs to be enhanced. Simultaneously, efforts must be made to explore and strengthen personnel cooperation, expand the coverage of funding support, and improve the quality of the literature.
舒芬太尼在麻醉学中的应用已成为一个热门研究领域。然而，基于文献的舒芬太尼文献计量分析有限。因此，本研究旨在综述舒芬太尼在麻醉学中的应用，并评估该领域的研究现状和趋势。
我们检索了Web of Science核心合集中的SCI-Expanded、SSCI和CPCI-S数据库，作为2003年1月1日至2023年12月31日发表文章的数据源，并使用文献计量和VOSviewer软件从作者、期刊、国家、机构及其合作网络以及关键词网络等方面对文献进行可视化和分析。
我们的分析包括1473篇关于舒芬太尼在麻醉学中应用的相关出版物。出版物总数呈上升趋势；研究排名前三的国家是中国、美国和法国；发表相关文章最多的前三所大学是安徽医科大学、首都医科大学和浙江大学；发表数量最多的研究集中在；目前，该领域的研究主要集中在舒芬太尼的应用范围、方式和优势；不良反应；以及舒芬太尼与其他药物联合使用的效果。麻醉学中使用舒芬太尼的不利因素以及提高其安全性和有效性的方法是研究的热点。未来的研究应探索人群适用性和剂量利用、新型药物组合、非阿片类辅助药物和技术创新。
越来越多的出版物表明，研究人员对麻醉学中舒芬太尼的使用领域表现出兴趣，并且正在进行的研究处于相对成熟的水平。虽然国际社会已经建立了强大的合作基础，但研究人员、机构和国家之间的合作仍需加强。同时，必须努力探索和加强人员合作，扩大资金支持的覆盖范围，并提高文献质量。
